https://biomarkersofthefuture.com/biomarkers-of-the-future daily 1.0 2023-06-20 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1665579840592-E8TLWMQF0YALJ8U5XICT/Fond+Biomarker+of+Paris+2019+-+Copie+%282%29.png Biomarkers of the Future https://biomarkersofthefuture.com/contact daily 0.75 2021-10-18 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1631289875004-O9JJL56Z36FTYJ6LM954/logo_Overcome_vermillon+sans+souligne%CC%81.png Contact https://biomarkersofthefuture.com/support21 daily 0.75 2021-09-10 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1631289877382-N2CKQNVBDH8DFXHU20Y3/Olink-Accelerate_Black+%281%29.png Support Identifying multiple proteins that form a signature are much more powerful and reliable than looking at a single protein at a time. Achieving this you need to cast a wide net of as, that studies hundred to thousand of proteins simultaneously, in everything from a few to a large number of human samples without losing in specificity or sensibility. This makes it possible to find the key biomarkers that form a “protein signature”. These types of signatures, or biomarker profiles, will enable you to get new insights and a better understanding of biology and pathophysiology. They will help you to find biomarkers for stratifying patients, to identify predictive markers that are able monitor development of disease. They will serve as tools for selecting the optimal therapy to the right patient as well as assessing the safety and efficacy of the treatment. We at Olink® Proteomics provide these tools with validated protein panels that can identify such profiles and provide the basis for more finely tuned diagnostic tools. Olink Biomarker panels enable rapid, high-throughput analysis with exceptional data quality and minimal consumption of biological samples. Only 1 µl of sample is needed to address 92 biomarkers simultaneously and each panel is sufficient for 96 samples. All assays are rigorously quality controlled, and our validation data is made freely available on our website (https://www.olink.com/). Olink Proteomics service suppliers or can choose to let Olink Proteomics in-house experts run their samples for them, using the Olink Proteomics Analysis Service. https://biomarkersofthefuture.com/paris-2 daily 0.75 2021-09-10 https://biomarkersofthefuture.com/evaluation-21 daily 0.75 2021-09-10 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1631289879483-V354MC78LQFQVXUPBZJM/Platform.png Evaluation21 - RATE YOUR BMP 20 EXPERIENCE https://biomarkersofthefuture.com/paris daily 0.75 2021-09-10 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1631289887034-3AQ4T9J9US1C369LXVZV/opera-garnier-paris-visite-900x500.jpg Paris - Opéra Garnier A masterpiece of architectural opulence, the Opéra Garnier – also known as the Palais Garnier – still exudes the same enigmatic atmosphere it radiated in the late 1800s. This palpable sense of intrigue and mystery that permeates the opera is due in part to its awe-inspiring Old World interiors as well as Gaston Leroux, the author of "Phantom of the Opera”, for which the Garnier served as inspiration. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1631289887038-81MIIW2V2O047THL89PV/1030.jpg Paris - Le Marais Straddling the 3ème and 4ème arrondissements (districts), Le Marais is one of Paris' oldest and coolest districts – so cool, in fact, that French writer Victor Hugo (author of "The Hunchback of Notre Dame" and "Les Misérables") called it home. With all of its cobblestone streets, stately stone architecture and tucked away courtyards, it's easy to feel as if you're strolling through medieval Paris. Back in the day, Le Marais housed some notable French royalty. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1631289887041-SYKFARO916AVVTX93VJ9/10.png Paris - Musée d'Orsay Housed in a former railway station along the Left Bank, the Musée d'Orsay is regarded for its rich collection of impressionist works. You'll see paintings by French artists like Degas, Monet, Cezanne, and Van Gogh, among many, many others. The museum also houses a number of sculptures, as well as photography and even furniture displays. https://biomarkersofthefuture.com/yr2020 daily 0.75 2021-09-10 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1631289895537-FHHR9WL6XSL8ZFZZCMKJ/Koeken%2Bphoto.jpg Young Researchers 2020 - Valerie Koeken Abstract: Inflammatory markers in the cerebrospinal fluid linked to mortality in tuberculous meningitis Valerie Koeken is a biomedical scientist, who recently finished her PhD at the Radboudumc in Nijmegen, the Netherlands. In her research, she aims to identify the beneficial immune responses which contribute to prevention of Mycobacterium tuberculosis infection, and the detrimental inflammatory responses which contribute to immunopathology, for example in tuberculous meningitis. Currently, she is working as a post-doctoral researcher at the Centre for Individualised Infection Medicine (CiiM) in Hannover, Germany, to improve our understanding of tuberculosis immunology using a systems biology approach. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1631289895543-2UNI9BQBTGNOAZ5QJ8Z1/Milanic+photo.jpg Young Researchers 2020 - Romina Milanic Abstract: Blood biomarker profiling of covid-19 patients who recovered from moderate-to-severe form of SARS-COV-2 infection: results from a single centre prospective observational study Romina Milanic, MD, obtained her medical doctor degree at the University of Rijeka, Croatia in 2013. She also successfully concluded residency program in Clinical pathology and Biochemistry at the University of Udine, Italy in November 2020, practicing at the Institute of Clinical pathology of the University hospital of Udine, where she will be appointed as a medical doctor consultant from Decembre 2020. Her previous experiences include teaching assistant position at Department of Microbiology and parasitology of the University of Rijeka and collaboration as a research associate at Drive AB project concerning antibiotic stewardship. Her current major scientific and clinical interest is focused on exploring laboratory diagnostics of autoimmune diseases. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1631289895550-8MZ7L8RZK0LCVQ5AAEWI/Salib+photo.jpg Young Researchers 2020 - Madonna Salib Abstract: PICP and gal3 in 2773 pts in hemodialysis independently predicted mortality. It would have been interesting to see how these 2 bmks performed relative to a cardiac bmk. The effect of study drug on the 2 bmks is not reported: is it there? I guess not. Dr Madonna Salib is a pharmacist with a background in pharmaceutical industry. She holds an Erasmus Master’s degree in Quality in Analytical laboratories and Data Analysis. She has research experience as a guest researcher at the National Institute of Standards and Technology (NIST) in Gaithersburg, Maryland, USA. She is currently working on her PhD project as a Marie Curie Early Stage Researcher (http://improvepd.eu/) at Centre d'Investigation Clinique Plurithématique, INSERM, CHRU de Nancy, Université de Lorraine. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1631289895520-KBNT1KSG4YV3M7H00ET0/Chandramouli+photo.jpg Young Researchers 2020 - Chanchal Chandramouli Abstract: Sex diff in biomarkers related to CMD in HFpEF Dr. Chanchal Chandramouli graduated from the University of Melbourne in 2016, specialising in Cardiac Physiology (Sex differences in diabetic cardiomyopathy). She is currently a Research Fellow at the National Heart Centre Singapore (NHCS), as well as an Assistant Professor in Duke-NUS Medical School. Experienced in both basic science and clinical research, her current clinical research interests include cardiometabolic disorders, sex differences and heart failure. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1631289895527-MM9P06HQFXKS6GHDL4B6/Dubois-Deruy+photo.JPG Young Researchers 2020 - Emilie Dubois-Deruy Abstract: Olink analysis of several organs in a murine model of co-exposure to cigarette smoke and obesogenic diet Dr. Emilie Dubois-Deruy is a post-doctoral researcher at the Institute Pasteur of Lille, who obtained a PhD in 2010 by studying the post-translational modifications of contractile proteins as new biomarkers of left ventricular remodeling. Her current research focuses on mitochondrial oxidative stress in cardiac hypertrophy development and strategies to prevent these mechanisms in several experimental models. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1631289895523-S347XQSOZ4295OYINUVW/Deniau.jpg Young Researchers 2020 - Benjamin Deniau BMP 2019 competition winner Dr Benjamin Deniau, MD PhD, is physician in Anaesthesiology and Critical Care Medicine service at the Hôpital Lariboisière, University of Paris, France. He works at INSERM unity 942 directed by the Professor Alexandre Mebazaa. His research is based on cardiovascular biomarkers in stress conditions. His PhD was focused on dipeptidyl peptidase 3 (DPP3) as a myocardial depressant factor in septic and catecholaminergic AHF. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1631289895540-U7CKO9WX2VRLIHAKFHE4/Masini+photo.jpg Young Researchers 2020 - Gabriele Masini Abstract: The effect of different definitions of iron deficiency on its prevalence and its relationship with patient characteristics and prognosis in chronic heart failure Dr Masini is a cardiologist, who has ust finished his training fellowship program at the University of Brescia, directed by Professor Marco Metra. He spent a semester as a research clinical fellow at the University of Glasgow under the supervision of Professor John Cleland and Dr Pierpaolo Pellicori. His research activity focuses on the role of iron deficiency and on new ultrasound tools to better quantify congestion in heart failure. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1631289895517-F4TR22ZSP55MPTXHY1QB/Cauwenberg+photo.jpg Young Researchers 2020 - Nicholas Cauwenberghs Abstract: Proteomic Characterization of Subclinical Heart Maladaptation in the Community Dr. Nicholas Cauwenberghs is a post-doctoral researcher at the University of Leuven (Belgium), who obtained a PhD in Cardiovascular Medicine in 2019. His research focuses on integrative biomarker profiling for assessment of cardiac health in the general population. In particular, he utilises advanced computer modelling approaches to construct integrative biosignatures from genetic, proteomic and imaging data for early detection and prevention of cardiac disease in the community. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1631289895530-N3DZIJ8QO0I9GIWKP1J2/Helan+photo.jpg Young Researchers 2020 - Martin Helán Abstract: A pilot study on oxidative stress biomarkers in septic shock Martin Helan is a young anesthesiologist, intensivist and researcher working in Saint Anne’s University Hospital and International Clinical Research Centre in Brno, Czech Republic. Scientifically, he focuses mainly on the study of sepsis, septic shock and MODS. Together with his cooperators, he works on a project monitoring changes in human immunity in patients with progressing sepsis. He gained his previous scientific experience during a long-term internship at the Mayo Clinic, Rochester, USA https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1631289895547-F4G2D7SHF3ZBPSHC6KCT/Novelli+photo.jpg Young Researchers 2020 - Deborah Novelli Abstract: Endothelial damage in septic shock patients as evidenced by circulating Syndecan-1, Sphingosine-1-phosphate and soluble VE-cadherin: effects of albumin supplementation Since October 2018, I am the Responsible of the Biobank SATURNE, certified ISO 9001:2015, at the Cardiovascular Medicine Department at Mario Negri Institute for Pharmacological Research IRCCS in Milan, where I manage and coordinate the collection and storage of biological samples from different clinical pharmacological trials in the field of cardiovascular diseases and intensive care. I graduated in Biology Applied to Biomedical Research at University of Milan (110/110 cum laude) in 2012 and after that I started a fellowship recruited in the three year-training program of the School for Pharmacological Research Specialists, in the Laboratory of Cardiovascular Clinical Pharmacology, Department of Cardiovascular Research, at the Mario Negri Institute. At the end of 2018 I obtained the PhD in Pharmacological Science, in the Cardiopulmonary Physiopathology Laboratory, where I carried out projects of pharmacological research in animal models of cardiac arrest and cardiopulmonary resuscitation, and pulmonary hypertension. During these years, I developed skills in organizing and coordinating experiments, histochemical and immunohistochemical techniques and collaboration in in vivo models. https://biomarkersofthefuture.com/2019 daily 0.75 2021-10-18 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1634569526308-LXWFI50EAP0FFRW3ADBG/IMG_7162.JPG 2019 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1634569646295-QQWCSHTFB5UDYRETDZD8/IMG_7120.JPG 2019 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1634569647079-ZZU9A0104WG80ZBZ963Y/IMG_7121.JPG 2019 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1634569655996-S80XMM2PFCI0PF9EKGAL/IMG_7122.JPG 2019 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1634569658158-M490APZIXUAR71D59QLS/IMG_7126.JPG 2019 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1634569668706-34R1XCR5QCAF94ZUN4UP/IMG_7127.JPG 2019 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1634569669920-Z21C6ADNX3WVQQ0GVNG4/IMG_7131.JPG 2019 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1634569678166-M1DCHH1PB32OL6X94MZM/IMG_7137.JPG 2019 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1634569680054-H6X907M0VD1DYQ49L22L/IMG_7145.JPG 2019 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1634569688441-VCOQ3AEFGTSG1SVIP1EZ/IMG_7149.JPG 2019 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1634569690424-4C6MH7L063YCBGRGC3YL/IMG_7156.JPG 2019 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1634569698599-XKMW1QFUO6ATP0LCT8F5/IMG_7166.JPG 2019 https://biomarkersofthefuture.com/scientific-programme daily 0.75 2023-07-31 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/7b079751-e920-45ba-9d5b-ad68204be1a1/BFC+21+white.png Scientific Programme - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/fa8d6c8c-a739-47e4-8717-7c38b6914bd6/2.png Scientific Programme - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/39e75b88-b71f-4ae0-91c5-11d05c3d6891/Texte-Biomarkers-of-Paris-Bandeau-1300px-sans-noms.png Scientific Programme - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1666255892625-2VJFDZAGB3RANYGYEQSQ/unsplash-image-Mm1VIPqd0OA.jpg Scientific Programme https://biomarkersofthefuture.com/evaluation20 daily 0.75 2021-09-10 https://biomarkersofthefuture.com/home daily 0.75 2022-11-14 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1634566630799-MNETFM8LIU1COH7O3BTV/Prof%2BMebazaa%2B.jpg Welcome https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1666090227126-YUSCPVSUP3DMZYG0WCLF/website+abstract.jpg Welcome https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1665067691822-E05QKKNKJQAW4UP4KXKL/2.jpg Welcome - Preliminary Programme is now out https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1665067692038-V8HZBN6J7C5VD3XHUDB4/3.jpg Welcome - Partnership packages now available https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1665584416595-MK28RI1TBX5N75DMJSMT/4+%282%29.png Welcome https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1631289898566-0UR4IZOJOBJSGU5A00W4/Laribois%C3%A8re+2.jpg Welcome Hôpital Lariboisière, Paris, where the inaugural BMP took place https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1e7672d2-3513-4dbd-8404-d44de8e6ada1/Broekstra.jpg Welcome - Reinder Broekstra Session 6: Biobanks Societal trust https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/85483ac0-cbd9-4969-8696-4af25690f211/Baragetti.jpg Welcome - Andrea Baragetti Session 7: Human metabolism and cardiovascular disease Plasma "omics" for the prediction of cardiovascular risk and the evolution of atherosclerosis https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/330ac00c-c91c-4086-a3d2-53d7abb2b92a/Stephan+Greene.jpg Welcome - Stephen Greene Session 2: Biomarkers are eagerly needed https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/fc358753-7adf-4bea-9dc1-c392515abdb2/Amodio.jpg Welcome - Donato Amodio Session 3: Omics and successes in drug discovery HIV and omics https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/789c4c48-5374-4d68-98db-0f14e990f254/Anne-Li+Lind.jpg Welcome https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1665584560427-Q1OYJ2137AZE04DXA4AV/Sliwa.jpg Welcome https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1665584579185-KXU4XPZOT5BDLL89C8ZS/Ip.jpg Welcome https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1665584591065-7LE0STDORD2NGLR7UJJX/Mina-Hur.jpg Welcome https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1665584614645-4ADW6KF7M1OGKZNU0XIN/Jon%2BCunningham.jpg Welcome https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1665584626895-T8F1LG6319JT5DWR1BAJ/Van+Spall.jpg Welcome https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1665584677687-KF7T4GT5NYR597T41IHP/Bekri.jpg Welcome https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1665584726702-1BC1TK518O8BJ5SLXOYK/Muthiah%2BVaduganathan.jpg Welcome https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1665584638125-KUAZTI7W82UYU2PFECIH/Maja-Cikes.jpg Welcome https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1665584663054-8K5PLT80G0ZVWLHXFGT1/Stefansson.jpg Welcome https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1665584648721-PS1OYDMUVSAO66C92V26/Johansson.JPEG Welcome https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/74ac0277-16d1-4f2f-947e-8043d6888b8b/Damy.jpg Welcome https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/bf7cce80-5880-4f47-a72b-32d4334e1717/Virtual+platform.jpg Welcome - The BMF 2022 Virtual platform is now open. Click here to be directed You can access the BMF 22 virtual platform from now. Visit the platform to learn more about the speakers, program and view and vote on the Young Researchers e-Posters. Click here to download the platform guide. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1665581066662-ZYAWK416DN7EO06YE965/Fond+Biomarker+of+Paris+2019+-+Cropped.png Welcome https://biomarkersofthefuture.com/venue daily 0.75 2021-09-10 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1631289901733-GGCDE2TIZH6AIIW8DSMN/Hospital+plan.PNG Venue AP-HP. Nord - Université de Paris 2 Rue Ambroise Paré, 75010 Paris Entry via: Door 10 Yellow / Porte 10 Jaune https://biomarkersofthefuture.com/eat-tremont daily 0.75 2021-10-18 https://images.squarespace-cdn.com/content/v1/5755bccb8259b515333df0e1/1475298692498-OR0RRZRYA5X3V1MX1E8R/image-asset.jpeg Eat https://images.squarespace-cdn.com/content/v1/5755bccb8259b515333df0e1/1466120130465-9BNATBEVMW9VCWH2KMA2/Stocksy_comp_461841-color.jpg Eat https://biomarkersofthefuture.com/speakers daily 0.75 2022-10-11 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/012ba4f9-eecc-49e5-a499-57c8bf999de1/Mina-Hur.jpg Speakers - Mina Hur Konkuk University, Seoul - South Korea https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/d2609514-3a46-44e1-86a1-4fd5c38b3bc5/Lina+Ya%27qoub.jpg Speakers - LinaYa'Qoub University of California - San Francisco San Francisco CA- United States https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/bb1826c6-cbb7-4bac-be89-fc269a4fff3e/Muthiah+Vaduganathan.jpg Speakers - Muthiah Vaduganathan Brigham and Women's Hospital, Bosten Ma - United States https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/aad62ca8-d5a7-4623-a8e9-cc42a7dd0bd2/Sliwa.jpg Speakers - Karen Sliwa University of Cape Town , Cape Town- South Africa Professor Karen Sliwa is a senior cardiologist working at the Division of Cardiology, Department of Medicine, Groote Schuur Hospital, University of Cape Town and at UCT Private Academic Hospital. Her special areas of expertise are heart failure, structural heart diseases such as cardiomyopathy and cardiac disease in pregnancy. She is the Director of the Cape Heart Institute, Faculty of Health Sciences, University of Cape Town- a translational cardiovascular research Institute with 7 working groups. Prof. Sliwa is widely recognised as a world expert in cardiovascular diseases (CVDs), with a special interest in reducing mortality in women with cardiac disease in maternity. She has contributed to better understanding on the pathophysiology, treatment options and awareness of peripartum cardiomyopathy (PPCM), a global disease particularly prevalent in African populations. She led and still leads several inter-Africa and global research projects, which have had a major impact for creating knowledge about CVDs common in Africa and other Middle-to-Lower income regions, leading to changes in policy. Her considerable experience in setting up simple, cost-effective registries and web-based data entry platforms have had a major impact on planning several innovative research projects and has facilitated the training of physicians from several African countries, including Mozambique, Nigeria, Cameroon, Uganda and Tanzania. Her translational research from bench-bed-to-population studies have led to a much better understanding of CVDs such as rheumatic heart disease and heart failure due to various causes and subsequently to improved patient care. She holds numerous awards such as the German Cardiac Society Paul Morawitz Award for Exceptional Cardiovascular Research ( 2013), a Honorary Doctorate University Diderot-Sorbonne, Paris, France (2017), European Cardiac Society Geoffrey Rose Award for Population Sciences ( 2019) and the South African Medical Research Council Gold award ( 2021). She has authored more than 350 publications, trained more then 30 post graduate students. Her work is highly cited ( H- index 88). Professor Sliwa leads several high-profile special interest groups including a dedicated EORP Working Group on PPCM of the Heart Failure Association of European Society of Cardiology and the World Heart Federation Expert Group on Neglected Cardiovascular Diseases. Over her distinguished career she has served in many notable roles, including chair of the South African Heart Failure Association ( HeFSSA), President of the South African Heart Association (2014-2016), President of the World Heart Federation (2019-2020) and currently Vice president Southern Region Pan African Society of Cardiology ( 2016-2021). https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/c4c8e4f9-db6d-4651-81fa-810220758901/Lefaucheur.jpg Speakers - Carmen Lefaucheur AP-HP, Nancy/Monaco - France https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/fc358753-7adf-4bea-9dc1-c392515abdb2/Amodio.jpg Speakers - Donato Amodio Ospedale Pediatrico Bambino Gesù Rome, Italy https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/56f103ed-0f9f-4fad-991c-0a7758e93eb7/Ip.jpg Speakers - Nancy Ip Hong Kong University of Science and Technology, Hong Kong- Hong Kong https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1634572819128-C5WYBHHAJN53WIO77MT6/Tromp%2Bphoto.jpg Speakers - Jasper Tromp National University of Singapore, Singapore - Singapore Jasper Tromp is a medical doctor (MD) who completed his PhD in Medicine (Cum Laude/Highest distinction) with a strong interest in global health and big data analytics. He is interested in the intersection between biomarkers and heart failure. What can biomarkers tell us about the underlying pathophysiology of heart failure and how can biomarkers be used in clinical practice are central questions to my research. He is currently a post-doctoral fellow at the National Heart Centre Singapore, Duke-NUS medical school and co-director of the "Cardiovascular Clinical Trial Data Management Centre" at the National Heart Centre. He manages and spearheads several international collaborations with academia and industry which have led to publications in top tier journals including Journal of the American College of Cardiology, Circulation, European Heart Journal and Lancet Global Health. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/330ac00c-c91c-4086-a3d2-53d7abb2b92a/Stephan+Greene.jpg Speakers - Stephen Greene Duke University Durham NC, United States Stephan Greene a cardiologist with a clinical and research interest in heart failure. He take care of patients with various types of heart failure, including patients who are best treated with medications and patients who receive advanced therapies like heart transplantation and mechanical assist devices. He became a heart failure cardiologist to help patients manage their heart conditions and best achieve their goals for their health. Hr is strongly committed to helping patients thoroughly understand their medical conditions and helping them make informed medical decisions aligned with their preferences. His research interests are focused on strategies and therapies to improve outcomes and quality of life for patients with heart failure. This involves research through clinical trials and through examining data from real-world clinical practice. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/33e7d8e5-e9c7-4ba8-ba0d-32a974a9e782/Maja-Cikes.jpg Speakers - Maja Cikes University of Zagreb Zagreb - Croatia https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/789c4c48-5374-4d68-98db-0f14e990f254/Anne-Li+Lind.jpg Speakers - Anne-Li Lind Olink Proteomics Uppsala - Sweden Anne-Li Lind is a doctor of medical science specialized in chronic pain research with more than 10 years of experience in medical molecular neuroscience and of human biofluid proteomic methods. She is excited about making contributions to public health and sustainability. She loves a challenge and particularly enjoy working with a focused, creative, multi-professional team to meet goals and requirements. She is delighted to conduct scientific investigations, collect and analyze data, read, interpret and communicate medical science in collaboration with study participants, public, clinicians, scientists, management, and students. Colleagues describe her as energetic, creative, driven, responsible and helpful. In a project She was able to turn complexity into concrete to-dos and get them done. She also enjoys vision and strategy work. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1507f9f9-413f-461c-8f3d-5e307862cd9e/Amrein.jpg Speakers - Melissa Amrein University of Basel, Basel- Switzerland Melissa Amrein is a PhD candidate at the University Hospital of Basel doing cardiovascular research, whereby her projects deals with analysing biomarkers for the diagnosis and prognosis of functional relevant coronary artery disease. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/5d9c12ac-b37c-46a4-a7d2-50d077fdd647/Bekri.jpg Speakers - Soumeya Bekri CHU Rouen, Rouen - France https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/2e82b46b-ed14-468b-afac-5e75b3e77619/Photo+SS.jpg Speakers - François Dépret University of Toronto, Toronto - Canada Dr Sabri Soussi completed his specialty training in Anesthesia and Critical Care in 2010 in France and had as of 2011 a clinical associate and then attending physician positions in the Medical Surgical and Cardiovascular ICUs of La Pitié-Salpétrière and Lariboisière-St Louis University Hospitals (Paris, France). In 2018, he obtained a master’s degree in “Clinical Research and Epidemiology” (Sorbonne University, Paris, France). He thereafter started in 2019 a PhD program “Genes, Omics, Bioinformatics and Systems biology” in the University of Paris. Dr SOUSSI published 32 peer reviewed articles in the last 5 years mainly in the field of shock states monitoring, management and novel biomarkers assessment (e.g., septic, cardiogenic, related to burn injury), in specialty-leading and high-impact medical journals (e.g., Anesthesiology Intensive Care Medicine). He set up a research collaborative network between his inner research group in Saint Louis and Lariboisière Hospitals, Paris, France and the academic group at St Michael’s Hospital, University of Toronto (Dr Claudia DOS SANTOS, Dr Laurent BROCHARD and Dr John MARSHALL). https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/2ff29fda-5fa3-402e-b644-812ad2162a96/Johansson.JPEG Speakers - Mattias Johannsson IARC, Lyon - France https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/74ac0277-16d1-4f2f-947e-8043d6888b8b/Damy.jpg Speakers - Thibaud Damy Henri Mondor University Hospital Paris, France Pr Damy’s field of interest are Heart failure and amyloidosis, through to their diagnosis and treatment. His particular current interests include early cardiac diagnostic markers, from biology to imaging. He is a co-author of 150 articles (>60 on amyloidosis). Professor Damy created the “Mondor Amyloidosis Network”, which involves all the clinical facilities for the diagnosis and and treatment of amyloidosis, in addition to a clinical research team. It rapidly became an important multidisciplinary network involving more than 40 healthcare professional. Since 2010, more than 2,800 patients have been referred to the centre for suspicion of cardiac amyloidosis . Professor Damy and his team created a wide educational programme to improve the knowledge and quality of life of the patients: Amylo Patient Education Program (Amylo-PEP). In 2017, the Mondor Amyloidosis Network was appointed Referral Center for Cardiac Amyloidosis in the Cardiogen FrenNetwork. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/024618d4-0cbf-4a02-9b7f-7617bef687e2/Van+Spall.jpg Speakers - Harriette Van Spall McMaster University, Hamilton - Canada https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/06f64fc3-6576-4653-98ca-01eda8763ccd/Lacey+new.jpg Speakers - Ben Lacey UK Biobank, University of Oxford, Oxford- United Kingdom https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/85483ac0-cbd9-4969-8696-4af25690f211/Baragetti.jpg Speakers - Andrea Baragetti University of Milan, Milan- Italy https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1e7672d2-3513-4dbd-8404-d44de8e6ada1/Broekstra.jpg Speakers - Reinder Broekstra University of Groningen, Groningen- Netherlands Reinder Broekstra conducts research into ethical legal and (psycho)social issues in genetics and genomics. His research interests focus on the implications of innovations, particularly with application of information technology. For example, the implications of consent, communication of findings, and other criteria for data repository in scientific research. His research during his PhD investigated factors affecting willingness to contribute (personal data) to large-scale, centralized data repositories for scientific (biomedical) research, specifically biobanks. Amongst other projects during his brief non-academic research career, he investigated the implications of introducing a mobile app for banking to the clients of a renowned bank in the Netherlands. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/aa158e89-2098-4f1c-9d34-0c68a50e80af/Jon+Cunningham.jpg Speakers - Jon Cunningham Brigham and Women's Hospital Bosten Ma - United States https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1666256062884-MBN2BVXCXK9CXUFDQTHM/unsplash-image-QrqeusbpFMM.jpg Speakers https://biomarkersofthefuture.com/2020 daily 0.75 2021-11-22 https://biomarkersofthefuture.com/scientific-committee daily 0.75 2022-10-10 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/5560ec6e-a4c8-457c-9a59-185c7d60d6de/Bayes-Genis.jpg Scientific Committee - Antoni Bayes-Genis Institut del Cor - Hospital Universitari Germans Trias i Pujol, Barcelona, Spain Dr. Antoni Bayes-Genis is chair of the Germans Trias Heart Institute (iCor), Director of the Cardiology Department at Hospital Universitari Germans Trias i Pujol (Badalona, Spain), Director of the ICREC (Heart Failure and Cardiac Regeneration) Research Program and Full Professor at Autonomous University of Barcelona. He has published over 4000 SCI papers with more than 10.500 citations. He has contributed to over 600 national and international conferences in oral format. He is inventor of 9 international patents, Director/Co-director of 13 PhD Thesis and has established several collaboration agreements with biotechnological companies. His research is focussed in two main areas, one more clinical and another basic-translational. From the clinical stand-point he is interested in novel biomakers for diagnosis and prognosis in heart failure and sudden death as well as telemedicine. At the basic-translational level he is interested in mesenchymal stem cells (adipose tissue-derived, circulating progenitors and umbilical cord-derived) and cardiac tissue engineering to salvage and restore injured myocardium. The ICREC group is also involved in tissue engineering projects on biocompatible polymers to develop bioactive structures with biomedical applications. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/3b07ae65-a715-4cba-b30c-4508dadc58d9/Janine_Poess.jpg Scientific Committee - Janine Pöss Herzzentrum Leipzig, Leipzig - Germany https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1634566630799-MNETFM8LIU1COH7O3BTV/Prof%2BMebazaa%2B.jpg Scientific Committee - Alexandre Mebazaa University of Paris, Paris - France Professor Alexandre Mebazaa is appointed by the University of Paris and is head of the anesthesia and critical care department of the Saint Louis-Lariboisière - Fernand Widal University Hospitals. Since January 2019, he heads the MASCOT (Cardiovascular Markers in Stressed CONdiTions - UMR-S 942) research unit, which is funded by INSERM and the University of Paris. His research interests include the mechanisms of contractile impairment during acute heart failure and worldwide studies on biomarkers in acute cardiac insufficiency. He was a member or Chairman of several study steering committees such as SURVIVE, COMPOSE, TRUE-HF, FROG-ICU, Natrium, Strong-HF. Since 2020 he has been the FHU PROMICE coordinator (Hospital-University Federation) and co-director for the project “Precision medicine for the comprehensive care of seriously ill patients”), the objectives of which are to show that precise phenotyping of patients associated with biophysical models and big data improve decision-making systems in the perioperative period. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/926b0d2c-8920-4672-8949-a539d155d88a/Celutkiene.jpg Scientific Committee - Jelena Čelutkienė Vilnius University, Vilnius - Lithuania https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/73688233-1728-47cf-a376-64ddb6520647/Camille+Gabeaux.jpg Scientific Committee - Camille Gobeaux Hopital Cochin Paris - France Professor Camille Chevenier-Gobeaux is affiliated with AP-HP and University of Paris. She has participated in the 3 previous editions of the BMF. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1634632951491-PE6NUSLUWRDCWNV11UDX/Jane-lise-Samuel.jpg Scientific Committee - Jane-Lise Samuel University of Paris, Paris - France Pr Jane-Lise Samuel (University of Paris 7, France) opened the symposium by providing an overview of sex differences in normal and pathological hearts. Indeed, lines of evidence indicate that cardiovascular sexual dimorphism exists in normal and diseased hearts—from the cellular level (cardiomyocyte, endothelial cell, vascular smooth muscle cells) to the organ. Dr Samuel also highlighted the sex-specific differences from the impact of ageing, cardiac hypertrophy, heart failure, and of exposure to ischaemic insult or chemotherapy. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1666255967500-0NKOBDBATCMX5713YVX9/unsplash-image-1PpyUZceg_I.jpg Scientific Committee https://biomarkersofthefuture.com/support daily 0.75 2022-10-18 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/347f75dc-8cb8-46dc-b1b1-3d4c41b052d7/2.png Support - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/fed08d0f-c4b5-4e1f-938d-c306f2f25925/1.png Support - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/18e7ef5e-7c74-4592-a7d7-fd1077c85045/BMF+22+Partnership.png Support - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://biomarkersofthefuture.com/prerecording daily 0.75 2021-11-22 https://biomarkersofthefuture.com/young-researchers daily 0.75 2022-11-07 https://biomarkersofthefuture.com/stream daily 0.75 2022-11-15 https://biomarkersofthefuture.com/2023 daily 0.75 2022-11-15 https://biomarkersofthefuture.com/evaluation daily 0.75 2022-11-16 https://images.squarespace-cdn.com/content/v1/613b82122bb4a742b2f9d464/1668640718867-64YPEFTQTOIJ9NZVA73E/Virtual+platform.jpg Rate your experience https://biomarkersofthefuture.com/drink-tremont daily 0.75 2025-05-12 https://images.squarespace-cdn.com/content/v1/5755bccb8259b515333df0e1/1475298641096-U9QT0BCPH1WZ5V6RVG28/image-asset.jpeg Drink https://images.squarespace-cdn.com/content/v1/5755bccb8259b515333df0e1/1466120517882-GMTUN8QUTQPXD3SSUKAE/Stocksy_comp_486556.jpg Drink https://biomarkersofthefuture.com/visit-tremont daily 0.75 2025-05-12 https://images.squarespace-cdn.com/content/v1/5755bccb8259b515333df0e1/1475298596761-AFLRXNLFCGXLKC1X3ZVD/image-asset.jpeg Visit https://images.squarespace-cdn.com/content/v1/5755bccb8259b515333df0e1/1466119893918-X0SATSKR7JA3GP361K3R/Stocksy_comp_821143-crop.jpg Visit